High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in history

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

MedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 729. in SA
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »

'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »

Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
مصدر: Breakingviews - 🏆 470. / 51 اقرأ أكثر »

Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »